Lewis Hay III
Director · Elevance Health, Inc.
Individual
- 2025
- May 15, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lewis Hay III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher E. Kubasik - $4.27M in LHX purchases and sales in the last 12 months
- Samir Mehta - $3.69M in LHX purchases and sales in the last 12 months
- Jon Rambeau - $2.05M in LHX purchases and sales in the last 12 months
- Melanie Rakita - $1.77M in LHX purchases and sales in the last 12 months
- Gail Boudreaux - $1.00M in ELV purchases and sales in the last 12 months
- Charles Morgan Kendrick Jr. - $911K in ELV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lewis Hay III?
Lewis Hay III is a corporate insider, tracked as Director of Elevance Health, Inc. (ELV). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lewis Hay III last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 4 filings going back to 2025.
